A carregar...
Update on optimal use of omalizumab in management of asthma
Omalizumab is a humanized monoclonal anti-IgE antibody recently approved for the treatment of severe allergic asthma. This drug inhibits allergic responses by binding to serum IgE, thus preventing interaction with cellular IgE receptors. Omalizumab is also capable of downregulating the expression of...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3140296/ https://ncbi.nlm.nih.gov/pubmed/21792319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S14520 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|